Novel strategies for prediction and control of advanced breast cancer via nanoscaled epigenetic-based biosensors
Finish Year: 2012
Chief Investigator: Professor Matt Trau
Institution: University of Queensland
National Collaborative Breast Cancer Research Grant Program
Alternative Title: Combining nanotechnology with genetics to help better manage advanced breast cancer through early detection
This project explores novel strategies for prediction and control of advanced breast cancer. It is widely accepted that early detection is a major weapon which can be used very effectively against cancer. Professor Trau aims to combine the latest developments in molecular genetics (epigenetics) with the latest developments in nanotechnology (nanoscaled biosensors), to create and clinically test novel diagnostic technology. This could be used for and have a major impact in the early detection, prediction and treatment of advanced breast cancer.